HCA:NYE-HCA Holdings Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 366.66

Change

+3.50 (+0.96)%

Market Cap

USD 26.31B

Volume

1.00M

Analyst Target

USD 147.05
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
DVA DaVita HealthCare Partners Inc

N/A

USD 13.14B
THC Tenet Healthcare Corporation

N/A

USD 12.31B
UHS Universal Health Services Inc

N/A

USD 11.60B
EHC Encompass Health Corp

N/A

USD 9.52B
CHE Chemed Corp

N/A

USD 7.84B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.90B
BKD Brookdale Senior Living Inc

N/A

USD 1.11B
AMN AMN Healthcare Services Inc

N/A

USD 1.00B

ETFs Containing HCA

ZWHC:CA BMO Covered Call Health C.. 4.84 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.46 % 0.00 %

N/A

N/A
MHG:AU Magellan Global Equities 4.24 % 0.00 %

N/A

USD 0.10B
MGE:AU 4.11 % 0.00 %

N/A

N/A
XLVE:CA 1.79 % 0.00 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
NASH 0.00 % 0.49 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

N/A

USD 1.32B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

N/A

USD 0.14B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.46% 70% C- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.46% 70% C- 87% B+
Trailing 12 Months  
Capital Gain 57.29% 65% D 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.29% 65% D 87% B+
Trailing 5 Years  
Capital Gain 169.19% 89% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 169.19% 89% A- 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 31.82% 78% C+ 89% A-
Dividend Return 32.72% 78% C+ 88% B+
Total Return 0.90% 33% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 36.98% 57% F 27% F
Risk Adjusted Return 88.49% 96% N/A 93% A
Market Capitalization 26.31B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.50 41% 53%
Price/Book Ratio 293.44 5% 1%
Price / Cash Flow Ratio 11.22 38% 35%
Price/Free Cash Flow Ratio 9.70 57% 49%
Management Effectiveness  
Return on Equity 11.95% 56% 68%
Return on Invested Capital 21.91% 91% 90%
Return on Assets 11.51% 95% 95%
Debt to Equity Ratio -2,095.21% 100% 99%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.